Mural Oncology (MURA) Competitors $2.59 +0.08 (+3.19%) Closing price 07/3/2025 01:04 PM EasternExtended Trading$2.59 0.00 (0.00%) As of 07/3/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MURA vs. VYGR, LFVN, ALMS, IPHA, ELDN, PROK, ENTA, SPRO, DERM, and DMACShould you be buying Mural Oncology stock or one of its competitors? The main competitors of Mural Oncology include Voyager Therapeutics (VYGR), Lifevantage (LFVN), Alumis (ALMS), Innate Pharma (IPHA), Eledon Pharmaceuticals (ELDN), ProKidney (PROK), Enanta Pharmaceuticals (ENTA), Spero Therapeutics (SPRO), Journey Medical (DERM), and DiaMedica Therapeutics (DMAC). These companies are all part of the "pharmaceutical products" industry. Mural Oncology vs. Its Competitors Voyager Therapeutics Lifevantage Alumis Innate Pharma Eledon Pharmaceuticals ProKidney Enanta Pharmaceuticals Spero Therapeutics Journey Medical DiaMedica Therapeutics Voyager Therapeutics (NASDAQ:VYGR) and Mural Oncology (NASDAQ:MURA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Do institutionals and insiders have more ownership in VYGR or MURA? 48.0% of Voyager Therapeutics shares are owned by institutional investors. Comparatively, 80.2% of Mural Oncology shares are owned by institutional investors. 6.4% of Voyager Therapeutics shares are owned by insiders. Comparatively, 2.2% of Mural Oncology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts rate VYGR or MURA? Voyager Therapeutics presently has a consensus target price of $13.39, indicating a potential upside of 308.23%. Mural Oncology has a consensus target price of $12.00, indicating a potential upside of 363.32%. Given Mural Oncology's higher probable upside, analysts plainly believe Mural Oncology is more favorable than Voyager Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Voyager Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Mural Oncology 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is VYGR or MURA more profitable? Mural Oncology has a net margin of 0.00% compared to Voyager Therapeutics' net margin of -126.49%. Voyager Therapeutics' return on equity of -27.36% beat Mural Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Voyager Therapeutics-126.49% -27.36% -21.06% Mural Oncology N/A -83.39%-70.70% Which has better valuation & earnings, VYGR or MURA? Voyager Therapeutics has higher revenue and earnings than Mural Oncology. Voyager Therapeutics is trading at a lower price-to-earnings ratio than Mural Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVoyager Therapeutics$80M2.27-$65M-$1.46-2.25Mural OncologyN/AN/A-$128.51M-$7.67-0.34 Which has more risk & volatility, VYGR or MURA? Voyager Therapeutics has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, Mural Oncology has a beta of 3.03, meaning that its stock price is 203% more volatile than the S&P 500. Does the media refer more to VYGR or MURA? In the previous week, Mural Oncology had 2 more articles in the media than Voyager Therapeutics. MarketBeat recorded 2 mentions for Mural Oncology and 0 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.00 equaled Mural Oncology'saverage media sentiment score. Company Overall Sentiment Voyager Therapeutics Neutral Mural Oncology Neutral SummaryVoyager Therapeutics beats Mural Oncology on 9 of the 15 factors compared between the two stocks. Get Mural Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for MURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MURA vs. The Competition Export to ExcelMetricMural OncologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$43.35M$2.43B$5.53B$8.95BDividend YieldN/A1.77%5.38%4.09%P/E Ratio-0.348.8627.4020.24Price / SalesN/A674.45417.66125.07Price / CashN/A157.0736.6357.47Price / Book0.324.638.085.67Net Income-$128.51M$31.34M$3.16B$248.47M7 Day Performance4.44%3.25%2.81%3.29%1 Month PerformanceN/A6.80%3.69%5.18%1 Year Performance-13.67%1.89%35.30%21.35% Mural Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MURAMural Oncology2.8579 of 5 stars$2.59+3.2%$12.00+363.3%-13.7%$43.35MN/A-0.34119News CoverageVYGRVoyager Therapeutics3.6912 of 5 stars$3.11-0.2%$13.39+331.2%-57.6%$172.94M$80M-2.14100LFVNLifevantage4.1409 of 5 stars$13.50+3.2%$30.50+126.0%+109.1%$170.47M$200.16M19.62260News CoverageALMSAlumis3.1132 of 5 stars$3.08+2.7%$22.86+641.6%N/A$170.03MN/A0.00N/APositive NewsIPHAInnate Pharma2.5895 of 5 stars$1.83+0.8%$11.00+501.1%-15.3%$168.69M$21.77M0.00220Positive NewsGap DownELDNEledon Pharmaceuticals2.0272 of 5 stars$2.80+3.1%$9.00+222.0%+22.2%$168.56MN/A-1.3410PROKProKidney1.8465 of 5 stars$0.57-3.4%$3.50+511.9%-70.4%$167.42M$80K-0.953News CoverageGap UpENTAEnanta Pharmaceuticals4.1118 of 5 stars$7.66+1.3%$18.00+135.1%-40.0%$163.66M$67.64M-1.69160Positive NewsSPROSpero Therapeutics3.92 of 5 stars$2.93+0.9%$5.00+70.9%+119.6%$163.54M$47.98M-2.29150DERMJourney Medical1.6809 of 5 stars$7.00-2.5%$9.50+35.7%+37.9%$163.31M$56.13M-17.9790DMACDiaMedica Therapeutics0.925 of 5 stars$3.75-3.8%$8.00+113.3%+24.1%$160.81MN/A-5.8620Gap Up Related Companies and Tools Related Companies Voyager Therapeutics Competitors Lifevantage Competitors Alumis Competitors Innate Pharma Competitors Eledon Pharmaceuticals Competitors ProKidney Competitors Enanta Pharmaceuticals Competitors Spero Therapeutics Competitors Journey Medical Competitors DiaMedica Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MURA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MURA Stock Alerts